Manufacturer record
Cooper Pharma Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Cooper Pharma Ltd (Uttarakhand) were declared Not of Standard Quality between May 2022 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Cooper Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Buprenorphin Injection I.P. (Noophin Injection ) | LM18898Mfg 2022-11 · Exp 2028-10 | Related Substances, Particulate matter, Sterility , Assay of Buprenorphine Hydrochloride eq. to Buprenorphine and DescriptionAssay | CDL, KolkataCDSCO lab | May 2025 |
| BUPRENORPHINE INJECTION I.P. | LM 18870Mfg 2020-12 · Exp 2026-11 | AssayAssay | RDTL GuwahatiState lab | May 2022 |
| BUPRENORPHINE INJECTION I.P. | LM 18730Mfg 2018-08 · Exp 2024-07 | AssayAssay | RDTL GuwahatiState lab | May 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.